Unlike other EIF4E family members in their cancer-promoting roles (50, 51), EIF4E3 competes with EIF4E1 for the same transcriptional and translational targets, such as VEGF, cyclinD1, through atypical binding to the cap and hinders tumor development by reducing the expression of these factors, which is important. This evidence concerns the gene EIF4E and cancer.